Diana Campelo Delgado,  —

Perceptions of a medication can predict treatment adherence and persistence — sticking with the same therapy — in people with multiple sclerosis (MS), a prospective observational study found. The findings were the result of a clinical study (NCT02488343) evaluating the profile of adherence to therapy in patients ages…

Restless legs syndrome, the name given to the considerable discomfort people feel in their lower limbs, accompanied by an irresistible urge to move them, more frequently affects multiple sclerosis (MS) patients than the general public, and significantly impacts sleep quality, a case control study shows. While the type of MS treatment used…

The MS Trust welcomes adolescents with a connection to multiple sclerosis (MS) to join as reporters for its YouTube channel, the U.K. charity announced. Since its April 2018 launch, MSTV has featured young people with MS or those close to them sharing their experiences and first-hand knowledge through…

A Phase 1 clinical trial investigating ANK-700 as a means to restore immune tolerance to myelin in people multiple sclerosis (MS) has begun dosing participants. Currently recruiting at a single site in Tennessee, the trial (NCT04602390) is expected to enroll up to 40 patients with relapsing-remitting…

Doctors in the U.K. are planning a “mega-trial” to investigate several marketed therapies — at the same time — as potential treatments to halt the progression, or even reverse the disabilities, of multiple sclerosis (MS). The world-first Octopus trial, named for its various arms, will enable researchers to concurrently…

ThermApparel is observing Multiple Sclerosis Awareness Month by  celebrating the fourth anniversary of its cooling vest, designed for multiple sclerosis (MS) patients and others with extreme sensitivity to heat. “Our mission was to provide customers with a state-of-the-art cooling vest that looks and feels great, and is extremely fashionable,” Kurtis…

Bristol Myers Squibb (BMS) and the American Music Therapy Association (AMTA) are partnering with singer and actor Ben Platt, and dancer, choreographer and actor Courtney Platt, to launch MS in Harmony, the first digital music therapy for patients with multiple sclerosis (MS). “We’re thrilled to have the chance…

The MS Society in the U.K. is hoping to raise £3.7 million ($5.2 million) to fund research aimed at developing new treatments for multiple sclerosis (MS). The funds will support research at the Society’s Centers of Excellence in Edinburgh and Cambridge over five years. “Our top priority…

The 2020 Barancik Prize for Innovation in MS Research has been awarded to neuroscientist Dwight E. Bergles, PhD, a Johns Hopkins University professor, for his work in understanding the function of brain cells in multiple sclerosis (MS). This international prize awards $100,000 to the recipient. Administered by the National MS…

Childhood trauma can affect disease progression of multiple sclerosis (MS) and treatment in adulthood, a study in mice suggests. The study shows that mice that experienced early-life trauma were more likely to develop an autoimmune condition and less likely to respond to common treatment with interferon beta. The study,…

Telemedicine is a feasible and effective method of remote care for multiple sclerosis (MS) patients during the COVID-19 pandemic, an Italian study suggests. The study, “Telemedicine during the Coronavirus Disease (COVID-19) Pandemic: A Multiple Sclerosis (MS) Outpatients Service Perspective,” was published in the journal Neurology International.

Lemtrada (alemtuzumab) may slow the progression of multiple sclerosis (MS) and lower the conversion rate of relapsing-remitting MS (RRMS) to secondary progressive MS (SPMS), a long-term study suggests. The results showed that patients converting to SPMS — in which a person’s disability gets steadily worse — were older,…

CXCL13, an inflammatory biomarker, may be a good marker of likely future disease activity in people with multiple sclerosis (MS), a study suggests. The study, “Intrathecally produced CXCL13: A predictive biomarker in multiple sclerosis,” was published in the Multiple Sclerosis Journal – Experimental, Translational and Clinical. Clinicians caring…

Children of diabetic mothers may be at more risk of developing multiple sclerosis (MS), a Danish national study suggests. The study, “Maternal diabetes and risk of multiple sclerosis in the offspring: A Danish nationwide register-based cohort study,” was published in the Multiple Sclerosis Journal. Previous studies have suggested a…

The prevalence of primary headaches — those with no clear cause — is high among patients with multiple sclerosis (MS), a new study suggests. Clinical screening of headache among MS patients could help tailor individualized treatments and ease the impact of the disease for these patients. The study, “…

Two global Phase 3 clinical trials, both comparing Sanofi Genzyme’s investigational tolebrutinib with its approved therapy Aubagio, are enrolling a total of 1,800 people with relapsing multiple sclerosis (MS), the company said. All patients in both studies — dubbed GEMINI 1 and GEMINI 2 — will…

Autologous hematopoietic stem cell transplant (AHSCT) induces a reduction in relapse rate and physical disability in patients with relapsing-remitting multiple sclerosis (RRMS) who respond inadequately to other treatments, a small study suggests. The study, “Selective cognitive dysfunction and physical disability improvement after autologous hematopoietic stem cell transplantation…

Multiple sclerosis (MS) has a greater impact on women, reducing their levels of physical activity and increasing sedentary behavior, a recent study has found. The study, “Does Multiple Sclerosis Differently Impact Physical Activity in Women and Man? A Quantitative Study Based on Wearable Accelerometers” was published in the…

There may be a better way of repairing the insulation surrounding damaged neurons that could lead to new treatments for multiple sclerosis (MS), a study suggests. The data showed that blocking the protein sphingomyelin hydrolase neutral sphingomyelinase 2, or nSMase2, could improve the quality of the myelin surrounding…

There is no significant association between multiple sclerosis (MS) and vitiligo, a skin condition in which patches of skin lose their color, a review study has found. The study, “Association of multiple sclerosis with vitiligo: a systematic review and meta-analysis,” was published in the journal…

The HLA-DR15 haplotype — a set of gene variants that tend to be inherited together — in the HLA-DRB1 gene plays a role in autoimmune response and, in combination with environmental factors, contributes to the development of multiple sclerosis (MS), a study suggests. The study, “…

The nutritional supplement NanoStilbene, developed by Therapeutic Solutions International, worked better to reduce neurological damage and disease symptoms in an animal model of multiple sclerosis (MS) than the market-leading MS therapy Copaxone, the company announced. NanoStilbene is composed of easily absorbed nano-particles of pterostilbene, a…

Aslan Pharmaceuticals announced it will develop Aslan003, a potent and highly selective next-generation modulator of the immune system, as a potential therapy for autoimmune diseases such as multiple sclerosis (MS). Aslan003 is a small molecule blocking the human enzyme dihydroorotate dehydrogenase (DHODH). This enzyme is believed to reduce…